Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
22 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Nanobiotix S.A.’s names, not what it holds today.
Patents granted
22
22 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 2 in 2023
Applications published
37
since 2001, to Dec 31, 2025
Names they are printed under
3
its own name
By yearGrantedApplications published
'10'11'12'14'15'16'17'18'19'20'21'22'23'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals7
Medical technology3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
NANOBIOTIX its own name
named as the applicant on its applications, in FR
32 publishedNANOBIOTIX its own name
FR, as the owner printed on each patent
5 publishedNANOBIOTIX S.A. its own name
FR, as the owner printed on each patent
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 21, 2023 | 11,819,548 | Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer | Pharmaceuticals | NANOBIOTIX S.A. |
| Aug 8, 2023 | 11,717,684 | Nanoparticles for use for treating a neuronal disorder | Medical technology | NANOBIOTIX S.A. |
| Nov 15, 2022 | 11,497,717 | Nanoparticles for use for treating a neuronal disorder | Pharmaceuticals | NANOBIOTIX S.A. |
| Oct 18, 2022 | 11,471,482 | Nanoparticles for use in enhancing brain performances or in treating stress | Pharmaceuticals | NANOBIOTIX S.A. |
| Mar 22, 2022 | 11,278,723 | Nanoparticles for use for treating a neuronal disorder | Medical technology | NANOBIOTIX S.A. |
| Feb 15, 2022 | 11,247,054 | Nanoparticles for use for enhancing brain performances or for treating stress | Medical technology | NANOBIOTIX S.A. |
| Jan 25, 2022 | 11,229,705 | Coated nanoparticles for use for modulating electrical polarization of neurons | Pharmaceuticals | NANOBIOTIX |
| Aug 24, 2021 | 11,096,962 | Nanoparticles for use as a therapeutic vaccine | Pharmaceuticals | NANOBIOTIX |
| Jun 1, 2021 | 11,020,480 | Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer | Pharmaceuticals | NANOBIOTIX |
| Mar 16, 2021 | 10,945,965 | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof | Pharmaceuticals | NANOBIOTIX |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Mar 28, 2024 | 2024/0100163 | INORGANIC NANOPARTICLES COMPOSITIONS IN COMBINATION WITH IONIZING RADIATIONS FOR TREATING CANCER | Pharmaceuticals | NANOBIOTIX |
| Jan 4, 2024 | 2024/0000940 | POROUS, HIGH-Z AND CARBON-FREE PARTICLES AS RADIOENHANCERS | Medical technology | NANOBIOTIX |
| Dec 21, 2023 | 2023/0405123 | COMPOSITIONS OF NANOPARTICLES FOR TREATMENT OF CANCER | Pharmaceuticals | NANOBIOTIX |
| Jul 6, 2023 | 2023/0211175 | NANOPARTICLES, IONIZING RADIATION AND INNOVATIVE THERAPEUTIC COMBINATIONS THEREOF | Pharmaceuticals | NANOBIOTIX |
| Jul 7, 2022 | 2022/0212008 | NANOPARTICLES FOR USE FOR TREATING A NEURONAL DISORDER | Medical technology | NANOBIOTIX · patent 11,717,684 granted from it |
| Nov 18, 2021 | 2021/0353670 | NANOPARTICLES FOR USE AS A THERAPEUTIC VACCINE | Pharmaceuticals | NANOBIOTIX |
| Sep 16, 2021 | 2021/0283256 | INORGANIC NANOPARTICLES COMPOSITIONS IN COMBINATION WITH IONIZING RADIATIONS FOR TREATING CANCER | Pharmaceuticals | NANOBIOTIX · patent 11,819,548 granted from it |
| Jan 21, 2021 | 2021/0015756 | NANOPARTICLES FOR USE FOR TREATING A NEURONAL DISORDER | Pharmaceuticals | NANOBIOTIX · patent 11,497,717 granted from it |
| Dec 31, 2020 | 2020/0405750 | NANOPARTICLES FOR USE IN ENHANCING BRAIN PERFORMANCES OR IN TREATING STRESS | Pharmaceuticals | NANOBIOTIX · patent 11,471,482 granted from it |
| Mar 19, 2020 | 2020/0086120 | NANOPARTICLES FOR USE FOR ENHANCING BRAIN PERFORMANCES OR FOR TREATING STRESS | Medical technology | NANOBIOTIX · patent 11,247,054 granted from it |
What it applied for, 2024 to 2025: Medical technology 1 · Pharmaceuticals 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.